Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Resistance in PAD
NCT00262561Phase 4Completed
- Sponsor
- Aalborg University Hospital
- Start
- Jan 2006
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aspirin in Peripheral Arterial Disease (PAD), sponsored by Aalborg University Hospital. Primary endpoint: Myocardial infarction, Unstable angina, Cerebral infarction, Transitory cerebral ischaemia, Percutaneous or surgical vascular intervention, Sudden deterioration of symptoms, Amputation, Death at 5 years. Started Jan 2006; status: completed.
02
Drugs
aspirin
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT00262561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262561.